A new catechol-functionalized polyamidoamine as an effective SPION stabilizer by M. Galli et al.
Accepted Manuscript
Title: A new catechol-functionalized polyamidoamine as an
effective SPION stabilizer
Authors: Marco Galli, Beatrice Rossotti, Paolo Arosio, Anna
Maria Ferretti, Monica Panigati, Elisabetta Ranucci, Paolo
Ferruti, Anna Salvati, Daniela Maggioni
PII: S0927-7765(18)30783-5
DOI: https://doi.org/10.1016/j.colsurfb.2018.11.007
Reference: COLSUB 9772
To appear in: Colloids and Surfaces B: Biointerfaces
Received date: 9 July 2018
Revised date: 17 October 2018
Accepted date: 3 November 2018
Please cite this article as: Galli M, Rossotti B, Arosio P, Ferretti AM, Panigati M, Ranucci
E, Ferruti P, Salvati A, Maggioni D, A new catechol-functionalized polyamidoamine
as an effective SPION stabilizer, Colloids and Surfaces B: Biointerfaces (2018),
https://doi.org/10.1016/j.colsurfb.2018.11.007
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
 1 
A new catechol-functionalized polyamidoamine as an 
effective SPION stabilizer 
Marco Galli,a Beatrice Rossotti,a Paolo Arosio,b e Anna Maria Ferretti,c Monica Panigati,a,f Elisabetta 
Ranucci,a e Paolo Ferruti, a e Anna Salvati,d Daniela Maggionia e * 
a Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy. 
b Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria 16, 20133 Milano, Italy. 
c Laboratorio di Nanotecnologie, CNR-Istituto di Scienze e Tecnologie Molecolari, Via G. Fantoli 16/15 I, 
20138 Milano, Italy. 
d Groningen Research Institute of Pharmacy, University of Groningen, A. Deusinglaan 1, 9713 AV 
Groningen, The Netherlands. 
e Consorzio INSTM, via G. Giusti 9, 50121, Firenze, Italy. 
f Istituto per lo studio delle macromolecole, Consiglio Nazionale delle Ricerche (ISMAC-CNR), Via A. Corti 
12, 20133 Milano, Italy 
 
Graphical abstract 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 2 
 
 
Highlights 
 
 


 Catechol-functionalization of a polyamidoamine for tight linkage to SPION surface  
AC
CE
PT
ED
 M
AN
US
CR
IPT
 3 
 A new two-step ligand exchange to transfer SPION from apolar solvents to water  
 Zwitterionic polyamidoamine can impart stealthiness to SPION  
 Reflected light microscopy as a tool for investigating non emissive SPION in cells  
 ISA23 zwitterionic polyamidoamine-SPION nanocomposite as possible new MRI agent  
 
 
Abstract  
A synthetic strategy was established for decorating and stabilizing superparamagnetic iron oxide 
nanoparticles (SPIONs) with a zwitterionic linear polyamidoamine (PAA). The strategy was successfully 
tested with a PAA coded ISA23 previously found endowed with interesting biological properties, such as 
biocompatibility, degradability in aqueous media and stealth-like properties when injected in test 
animals. A post-synthetic functionalization with catechol-bearing moieties of a preformed PAA was 
successfully carried out. ISA23 was obtained by polyaddition reactions of methyl-piperazine and 
2,2-bis(acrylamidoacetic) acid. It was functionalized using nitrodopamine and 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide as coupling agent, to randomly form amide bonds with 
17% of ISA23 carboxylic groups (ISA23-ND). SPIONs were prepared by a thermal decomposition 
synthesis in 1-octadecene with oleic acid, and then transferred in water by two distinct ligand exchange 
procedures: i) the direct displacement of oleate molecules from SPION surface by ISA23 in a biphasic 
(n-hexane/water) environment; ii) the two-step method involving an intermediate small molecule, 
tetramethylammonium hydroxide, used as a transient transfer agent, which was in turn exchanged with 
ISA23-ND in a second exchange step occurring in water. The two-step procedure provided a 
SPION@PAA nanocomposite more stable than that obtained by the one-step procedure in the presence 
of an applied external magnetic field. ATR-FTIR spectroscopy, ζ-potential and thermogravimetric analysis 
(TGA) showed the presence of the ISA23 on the SPION surface. In particular, TGA showed that the 
ISA23-ND amount on the NPs accounted for 26% of the overall nanocomposite mass. The 
nanocomposite size was determined by both TEM (21.1±2.9 nm) and DLS measurements (hydrodynamic 
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size 100±28 nm). SPION@ISA23-ND were re-suspended after lyophilization reverting to their pristine 
dimensions. The SPION@ISA23-ND adsorption of BSA in water, considered as the first stage of 
phagocytosis, was very low, suggesting that ISA23 could impart stealthiness to SPION@ISA23-ND. 
1H-NMR relaxivity measurements showed an r2 value of 158 s-1 mmol-1 L (vs 100 s-1 mmol-1L for 
Endorem) at relevant clinical fields for magnetic resonance imaging (from 0.2 to 1.5 T). SPION@ISA23-
ND was tested on HeLa cells and their internalization was visualized by reflectance microscopy. 
Finally, with the aim of prepare a new dual magneto-optical system, a synthetic procedure to 
decorate SPION@ISA23-ND with a fluorescent dye was devised, even though the emission intensity of 
the resultant conjugate was lower than expected, possibly due to luminescence quenching caused by 
the closeness of emitting moieties to the SPION surface. 
 
Keywords: SPION, polyamidoamine, ligand exchange, relaxivity 
 
1. Introduction 
Superparamagnetic iron oxide nanoparticles (SPIONs) have long since been in the spotlight as 
promising candidates for a plethora of biomedical applications [1], including magnetic resonance 
imaging (MRI) [2], magnetic particle imaging (MPI) [3, 4], and magnetofluidic hyperthermia (MFH) [5, 6], 
thanks to their peculiar magnetic properties and high biocompatibility. The thermal decomposition of 
organometallic precursors in high-boiling organic solvents in the presence of surfactants such as oleic 
acid represents the best method to produce SPIONs with high magnetic properties [7, 8]. However, the 
resultant SPIONs are dispersible only in apolar organic solvents. In order to render them dispersible in 
water, hence suitable for in vivo uses, a hydrophilic stabilizing coating capable to prevent aggregation 
and sedimentation by either repulsion or steric hindrance is needed [9, 10]. Once injected in the 
bloodstream, the coating should also prevent SPION opsonization and recognition by the reticulo-
endothelial system (RES), thus prolonging their circulation time and maximizing their chances to 
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reaching the target tumour and concentrate there thanks to the so-called “enhanced permeability and 
retention” (EPR) effect [11]. 
One of the most widely adopted approaches to transfer NPs stabilized with hydrophobic coatings 
from organic to aqueous phases is the use of small amphiphilic organic molecules containing both a 
functional group with affinity for the NP surface and a second functional group with water affinity [12, 
13]. Amphiphilic polymers capable to form by intercalation stable weak interactions with the 
hydrophobic layer on NP surface and to expose to the environment the hydrophilic residues are also 
used [14, 15]. Alternatively, organic or inorganic polymers as for instance dextran [16], silica [17-20] or 
PEG [21-23] have been employed as biocompatible cover for magnetic nanoparticles obtained in many 
cases by coprecipitation methods. Not surprisingly, owing to the scientific and clinical relevance of 
superparamagnetic iron oxide nanoparticles in ferrofluids, a large patent literature on their stabilizing 
and biocompatibilizing covers exists [24-29]. 
In this work, a new polymeric SPION stabilizing coating was developed, based on an amphoteric 
polyamidoamine (PAA) coded ISA23, bearing both one carboxyl and two tert-amine groups per 
repeating unit (Scheme 1). ISA23 is highly hydro-soluble and was previously found to be biocompatible, 
biodegradable, and to exhibit “stealth-like” properties once injected in animals [30-32].  
Therefore, it could be expected that this polymer, properly functionalized to make it adhesive to 
SPION surface, was able to render them hardly recognized by the reticuloendothelial system (RES). 
ISA23, as all PAAs, is characterized by high structural versatility, being easily modified by 
copolymerization techniques, since the Michael addition reaction between prim- or sec-amines and 
bisacrylamides is specific and many different functions do not interfere and can be introduced as side 
substituents [33-36]. 
Thanks to the exceptional iron affinity of catechol, exploited by a variety of natural siderophore 
proteins [37], many examples of polymers bearing multiple catechol pendants were proposed for tightly 
binding NPs and stabilizing their colloidal dispersions [38, 39]. 
The first step of the synthetic strategy adopted was to introduce in ISA23 catechol pendants capable 
of giving stable bonds with the surface of iron oxide. The procedure consisted of conjugating a part of its 
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carboxyl groups with nitrodopamine by means of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) 
as coupling agent. The new SPION-ISA23 composites were fully characterized and their response to 
external magnetic fields of clinical relevance for magnetic resonance imaging discussed. A synthetic 
pathway to decorate with fluorescent probes SPION-ISA23 nanocomposites and obtain magneto-optical 
NPs for easier monitoring internalization in vitro [40] was also devised. 
 
2. Results and discussion 
2.1 Synthesis of ISA23-nitrodopamine copolymer conjugate 
The synthesis of ISA23 is reported elsewhere [30]. It was based on the Michael-type polyaddition of 
2-methylpiperazine with 2,2-bis(acrylamido acetic) acid (Scheme S1). The ISA23-nitrodopamine 
conjugate (henceforth called ISA23-ND) was obtained by reacting part of ISA23 side carboxyl groups 
with the amine group of 2-nitrodopamine using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) 
as coupling agent in a pH 5.5 2-(N-morpholino)ethanesulfonic acid (MES) buffer solution (Scheme 1). 
Nitrodopamine was preferred to dopamine owing to its stronger binding affinity and its higher stability 
towards oxygen- and metal-catalysed self-oxidation [6].  
ISA23-ND was purified by ultrafiltration through centrifugation (3000 Da cut-off filter). The retained 
portion was freeze-dried giving the product as a fluffy yellow solid. In order to maintain the amphoteric 
nature of parent ISA23, 17% of its carboxylic groups, as determined by the integrated intensities of the 
1H-NMR signals of the H atom  to the newly formed amide groups and of those of the H atom  to the 
unmodified ISA23 carboxyl group (Figure S1), were employed in the coupling reaction. 
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Scheme 1. Synthesis of ISA23-ND. 
 
ISA23-ND showed the typical UV-vis pH dependant absorption bands of nitrocatechols arising from 
different protonation states of the catechol group [41] (Figure 1a). At acidic pH the main peak was 
observed at 305 nm, which at higher pH shifted to 398 nm (with a minor absorption at ~280 nm) due to 
deprotonation of one hydroxyl group of catechol. After 24 h, at pH 12.5 two maxima in the absorption 
profile (409 and 500 nm), corresponding to the deprotonation of both the catechol hydroxyl groups 
were observed (blue trace in Figure 1a). 
The thermogravimetric analysis (TGA) of ISA23-ND in air showed different weight loss steps, with 
complete degradation at ~600 °C (see Figure 1b), similarly to what previously observed for ISA23 [42]. 
The first step (50-170 °C, ~15%) was ascribed to the release of hydration water. The second step (T 
onset 210 °C, ~60% ca) is tentatively attributed to the release of volatile 2-methylpiperazine. Indeed, it 
is known that PAAs decompose at high temperatures by retro-Michael reactions giving off the starting 
amines and bisacrylamides [43]. Finally, the residue completely volatilized by oxidation (T onset 460 °C, 
~25%). AC
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Figure 1. Characterization of ISA23-ND. a) pH dependent UV-vis absorption spectra in aqueous solution; b) TG 
thermogram; c) ζ-potential curve; d) ISA23 speciation curves versus pH. The dashed vertical line indicates pH 7.4. 
It is well known that linear PAAs are able to self-assemble in aqueous solution producing spherical 
nanoparticles [33, 34]. The DLS size distribution of ISA23-ND showed a main population formed by 
nanoaggregates with diameter smaller than 10 nm, with larger aggregates (intensities distribution 
Figure S2 top), accounting only for a negligible fraction of the material, as indicated by the volume 
distribution (Figure S2 bottom). 
The pH dependence of the ζ-potential (Figure 1c) accounts for the amphoteric nature of ISA23, the 
contribution of the small fraction of nitrodopamine moieties in ISA23-ND being negligible in this respect, 
and well agrees with its ionic species distribution (Figure 1d): positive charge at acidic pH, zero charge 
point at pH close to the isoelectric point (ISA23 IP = 5.5) due to zwitterion formation, and negative 
charge at basic pH, where both carboxyl and amino groups are deprotonated.  
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2.2 Synthesis of iron oxide @ ISA23-ND nanocomposite 
Iron oxide NPs were prepared by thermal decomposition of iron pentacarbonyl in refluxing 1-
octadecene, using a slightly modified literature procedure [44] (see Experimental part for details), 
providing oleate-capped NPs easily dispersible in n-hexane. DLS analysis (Figure S3) showed that the 
synthesized SPIONs were monodisperse, with slightly different sizes (mean hydrodynamic diameter 26.6 
± 3 nm and 30.8 ± 4.8 nm) by introducing small variations in the experimental conditions (Fe:OA ratio 
and absolute concentration). 
Two different methods were investigated for transforming the oleate-coated SPIONs into the target 
SPION@ISA23-ND nanocomposites. 
Direct one-step ligand exchange. Due to the insolubility of ISA23-ND in solvents other than water, 
literature methods that use polar organic solvent mixtures, such as THF – ethanol [45], for exchanging 
the capping ligand on the NPs could not be adopted. As an alternative approach, a direct exchange from 
hexane to water was first investigated. Ultrasonication was used to create an oil-in-water emulsion 
between the hexane dispersion of the oleate-coated NPs and the aqueous ISA23-ND solution, similarly 
to a literature procedure employing a catechol functionalized chitosan [46]. The effective ligand 
exchange (Scheme S2) was achieved only after the pH was adjusted at acidic values (pH ~3-4), to 
protonate the leaving oleate molecules, thus increasing their affinity for the organic phase [47]. 
TEM analysis (Figure S4) showed that the SPION@ISA23-ND nanocomposites prepared in this way 
were of regular shape and monodisperse, with a core diameter of 15.8 ± 1.7nm (dispersion 10.7%). A 
polymer coating shell of ~2 nm thickness was clearly visible around each NP. The occurrence of the 
ligand exchange was further evidenced by the ζ-potential curve (Figure 2a), which showed a pH 
dependence similar to that of the parent ISA23-ND (Figure 1c). Not unexpectedly, the mean NP size 
measured by TEM was smaller than that of the native SPION@OA provided by DLS (26-30 nm, see 
above), since the latter technique measures the hydrodynamic diameter that includes the solvent 
corona moving consistently to the NP. 
DLS analysis of SPION@ISA23-ND showed a single broad peak corresponding to a mean 
hydrodynamic diameter of ~180 nm (Figure 2b), consistent with the presence of large aggregates. The 
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tendency of ISA23 derivatives to form aggregates with iron oxide NPs was previously reported [48], even 
if the preparation procedure was different (coprecipitation method in the presence of the PAA). It was 
speculated that during the exchange of oleic acid and ISA23-ND at NP surface, while oleic acid detaches, 
NPs concentrate at the interphase between the two non-mixable solvents where they can partly 
aggregate prior to polymer binding to the NP surface. This hypothesis was supported by the evidence 
that NPs were mostly found in the interphase layer between hexane and water. 
 
Figure 2. Characterization of SPION@ISA23-ND. a) ζ-potential curve; b) DLS intensity size distribution; c) TG thermogram for 
SPION@ISA23-ND (blue trace) compared to the curve for ISA23-ND (red trace) of Figure 1b; d) Reflected light microscopy of 
SPION@ISA23-ND. HeLa cells were exposed to 30 µg/mL of NPs for 24 h. LAMP-1 staining with Alexa 488 was used to visualize 
the lysosomes in the cells (in green). Two distinct zoom-in snapshots are presented on the two lines. Left: superposition of 
reflected light (red) and lysosome fluorescence (green); left center: lysosome fluorescence only of the same snapshot; right: 
reflected light only. 
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The TG profile of SPION@ISA23-ND (Figure 2c, blue line) showed an initial weight loss due to 
hydration water (~3%), and that the weight loss due to the thermo-oxidative decomposition of organic 
layer (onset temperature of 210 °C) accounted for about the 11 % of the total nanocomposite weight. 
Cellular internalization studies were carried out in HeLa cells exposed for 24 h to 30 µg/mL NPs. No 
obvious sign of toxicity was detected, and cell density and phenotype were comparable to control 
untreated cells. Being NPs not fluorescent, reflected light microscopy [49-52] was used (Figure 2d). This 
imaging technique does not allow distinguishing single NPs, but has the merit of not requiring labelling. 
Moreover, it allows establishing correlation with confocal microscopy to confirm the particle location, 
especially in the case of multiple particles trafficking together into specific cell compartments. 
The lysosomes were visualized by immuno-staining the lysosomal protein LAMP-1 (green staining). 
From these images it can be concluded that the NPs were indeed internalized by the cells. As expected 
and commonly observed for most nanomaterials, the NPs were mainly present at lysosome level, as a 
consequence of a probable endocytic mechanism of internalization [53]. 
The NPs synthesized by this method showed heavy aggregation when placed under an external 
magnetic field, hampering relaxometric characterization. In order to avoid this detrimental effect an 
alternative procedure was developed. 
2.4  Two-step ligand exchange 
The two-step procedure involved the treatment of the hydrophobic oleate-stabilized NPs with an 
intermediate water-transferring agent, to be subsequently replaced by ISA23-ND. In this work, 
tetramethylamonium hydroxide (TMAOH) was used as water-transfer agent, a non-coordinating species 
commonly used as transfer agent for magnetite NPs [54-56]. 
According to the adopted procedure, dried SPION@OA were dispersed in a 0.125 M aqueous TMAOH 
solution, giving rise to a stable water suspension of SPION@TMAOH nanoparticles (first part of Scheme 
S3). The number size distribution from DLS measurements (Figure S5 bottom) showed that the large 
majority of the NPs had a mean hydrodynamic diameter equal to 40 ± 9 nm (from intensities graph, 
Figure S5 top). After washing twice by centrifugation to remove any TMAOH excess, SPION@TMAOH 
were treated with a threefold amount in weight of ISA23-ND, under shaking at room temperature for 72 
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h (Scheme S3). The so obtained SPION@ISA23-ND nanoparticles showed, after purification, an increase 
in hydrodynamic diameter, peaking at 100 nm, by Intensities distribution (Figure 3a). It is worth noting 
that, differently from the direct ligand exchange procedure, the OA/TMAOH exchange proceeded very 
fast (5 min duration) preventing the early SPION aggregation. Moreover, since the TMAOH/ISA23-ND 
exchange to give SPION@ISA23-ND occurred in a homogeneous aqueous phase, there were no 
favourable conditions for NP aggregation (see above direct ligand exchange procedure). 
The presence of the ISA23-ND on SPION surface was proved by several pieces of evidence. 
Attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) showed that the 
TMAOH/ISA23-ND exchange had actually occurred. Indeed, the two sharp and strong bands at 1488 cm-1 
and 950 cm-1, characteristic of TMAOH (CH3 asymmetric deformation mode and of the C-N asymmetric 
stretching [57], Figure S6 middle) were no more visible in the SPION@ISA23-ND spectrum (Figure S6 
bottom). The latter spectrum showed both the typical bands of polyamidoamine and the intense 
vibrational band due to iron oxide core, centred at 573 cm-1 (Fe–O–Fe stretching modes of the spinel 
structure of magnetite) [58]. 
The comparison of the ζ-potential curves of SPION@TMAOH and SPION@ISA23-ND (Figure 3b) in the 
pH range 3-10 further confirmed the occurrence of the ligand exchange. Particularly significant was the 
positive values at low pH shown by the PAA stabilized NPs that became strongly negative at higher pH 
values, according to the typical behaviour of amphoteric PAAs (see above). 
Moreover, TEM analysis (Figure 3c-e) showed NPs with a core size equal to 21.1 ± 2.9 nm (dispersion 
13.7%). and also in The presence of polymer coating surrounding the magnetic NPs was evident (Figure 
3d), even though the thickness of the polymer around the inorganic core was not constant. of irregular 
thickness was better highlighted by means of energy-selected imaging operating at 24 eV, which 
corresponds to the carbon component of the plasmon signal. The contrast-enhanced Figure 3d shows 
the polymer shell surrounding each NP as a white halo around the dark iron oxide core.  
The TG thermograms of SPION@ISA23-ND and ISA23-ND (Figure 3f) showed that NPs underwent a 
total weight loss of 26% at temperatures corresponding to the volatilization of ISA23ND (from 200 to 
600 °C). The weight loss was significantly higher than that observed for the nanocomposite obtained 
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with the direct ligand exchange method (11%, blue trace in Figure 2c). The thicker PAA coating was likely 
responsible for the observed nanocomposite stability in the magnetic field (see further). 
Moreover, SPION@ISA23-ND could be re-suspended after lyophilization and reverted to their pristine 
dimensions without sonication. 
 
Figure 3. Characterization of the SPION@ISA23-ND obtained by the two step procedure. a) DLS intensity distribution. b) ζ-
potential of SPION@TMAOH (blue) and SPION@ISA23-ND (red); c) TEM image with a zoom-in region; d) Energy Selected TEM 
image collected at 24eV ± 2eV corresponding to the conventional TEM image reported in c; e) TEM size distribution of the 
inorganic core; f) comparison between the TG profiles of ISA23-ND (orange) and SPION@ISA23-ND obtained by the two step 
procedure. 
The observed ISA23 stealthiness in the bloodstream [30] suggested that this property could be 
shared by SPION@ISA23-ND. Phagocytosis is triggered by plasma protein adsorption [59]. Reduced 
protein adsorption is considered an indication of plasma stability [60]. The adsorption of BSA (Bovine 
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serum albumin) as a representative model serum protein may be considered as an indicator of the non-
specific plasma protein adsorption [61-63]. SPION@ISA23-ND and SPION@TMAOH were incubated 90 
min at room temperature with a BSA solution in phosphate buffer pH 7.4. UV-vis spectroscopy was used 
to determine the residual BSA in the supernatant (Figure S7). SPION@TMAOH adsorbed a substantial 
BSA amount (23% of the original), whereas the BSA adsorption by SPION@ISA23-ND was negligible (~3% 
of the original), clearly suggesting that ISA23-ND coating could endow NPs with stealth-like properties. 
2.3 Synthesis of fluorescent SPION@PAA nanocomposites 
With the aim of obtaining a dual magneto-optical system, a procedure was devised to decorate 
SPION@PAA core/shell NPs with a fluorescent dye. The first step was to design a nitrodopamine-bearing 
PAA functionalized with the fluorescent dye RhodamineB (RhodB from now on). A PAA bearing a thiol 
group in 10% of its repeating units (ISA23SH10% in Scheme S4 top) was first reacted with nitrodopamine, 
following the same procedure described above for ISA23, resulting in functionalization of ~10 % of the 
free carboxyl groups (Scheme S4). In a second step, Michael addition of the ISA23SH thiol groups with 
the ethylmaleimido group of the functionalized-RhodB [58] produced ISA23SH-ND-RhodB polymer 
(Scheme S4 bottom), whose UV-vis spectrum is reported in Figure S8b. At 530 and 562 nm the typical 
peaks due to RhodB fragment were observed, while the bands due to the nitrodopamine pendent lie 
between 340 and 460 nm. 
ISA23SH-ND-RhodB underwent the above described two-step ligand exchange procedure, involving 
the intermediate formation of SPION@TMAOH. The excess of polymer was removed via magnetic 
recovery of the nanocomposite and subsequent discard of the supernatant, obtaining water-dispersed 
SPION@ISA23SH-ND-RhodB nanoparticles, with a hydrodynamic diameter of ca 80 nm (Figure S8a), and 
whose TEM image is reported in Figure S9. 
UV-vis spectroscopy of the purified particles showed superposition of the RhodB absorption band 
(λmax = 559 nm) to the broad band of iron oxide NPs (Figure S8a, red trace). The absorption bands of the 
nitrodopamine moiety were not visible since superimposed with the strong magnetite core absorption. 
The UV-vis spectrum of the supernatant after a centrifugation cycle (Figure S8b, black trace) did not 
show any RhodB signal, proving that the RhodB functionalized polymer was actually bound to the SPION 
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surface. Photoluminescence spectra were recorded for both SPION@ISA23SH-ND-RhodB and the free 
polymer. The emission spectra of the two compounds are almost superimposable, presenting the typical 
emission profile of RhodB with a maximum at 580 nm (Figure S10). This proved that the emission energy 
of RhodB did not significantly change after conjugation to SPION (580 vs. 583 nm). However, the 
quantum yields dropped of about one order magnitude (0.3% vs. 2.5%, respectively), as already 
observed in other magneto-fluorescent nanosystems [64], and this prevented to exploit this 
nanocomposite as luminescent probe for monitoring its cell uptake by confocal microscopy or flow 
cytometry. It was speculated that this was due to the random closeness of RhodB units to the SPION 
surface. 
 
2.5 Relaxometric characterization of two-step synthesized-SPION@ISA23-ND 
In the framework of biomedical applications, the measurements of the nuclear relaxivities, i.e. the 
efficiency in contrasting the magnetic resonance images (MRI), are suitable to predict the efficiency of 
magnetic nanoparticles as contrast agents for MRI [65]. The nuclear relaxivities r1 and r2 are defined as:  
𝑟𝑖 =
1
𝑇𝑖,𝑁𝑃+𝑤𝑎𝑡𝑒𝑟
⁄ − 1 𝑇𝑖,𝑤𝑎𝑡𝑒𝑟
⁄
𝑐
 
where T1 and T2 represent the longitudinal and transverse nuclear relaxation times in presence (NP + 
water) or absence (water) of magnetic nanoparticles and c is the iron concentration of the sample. 
In order to evaluate the ability of -SPION@ISA23-ND obtained by the two-step procedure to affect 
water nuclear relaxation times, 1H-NMR relaxivity measurements were performed at magnetic fields 
relevant for MRI tomographs (H = 0.2, 0.5 and 1.5T).  
At these fields, the1H-NMR longitudinal nuclear relaxivity, r1, values of SPION@ISA23-ND (Table S1) 
were comparable to those of the commercial product. However, at the same clinical fields, the 1H-NMR 
transverse nuclear relaxivity, r2, values of SPION@ISA23-ND (Table S1) showed a 50% increase in r2 
values compared to Endorem®, the withdrawn commercial T2 contrast agent still normally used for 
comparison in literature. Therefore, the r2 values obtained for SPION@ISA23-ND lets envisage a 
potential as T2 contrast agents in T2 imaging [66]. Moreover, the higher r2 values obtained in our system 
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with respect to Endorem allow to conclude that, with the same amount of contrast agent, the contrast-
to-noise-ratio in magnetic resonance images might reduce the injected doses. 
 
3. Conclusions  
A convenient strategy for decorating and stabilizing superparamagnetic iron oxide nanoparticles 
(SPIONs) with a zwitterionic biocompatible, degradable and stealth-like linear polyamidoamine was 
established. This procedure will be most likely employable for introducing catechol pendants on PAAs 
other than ISA23. This system exploited the well-known anchoring ability of catechol group to iron oxide 
and proved able to successfully stabilize SPIONs even for low amounts of catechol groups, to avoid 
detrimental effects on the polymer properties that might result from excessive functionalization. Owing 
to the versatility of PAAs as a polymer class, this opens the way to decorate SPIONs or other metal oxide 
nanoparticles with differently functionalized coatings. 
Relaxometric characterization of SPION@ISA23-ND nanocomposite showed that they hold promising 
NMR efficiency when dispersed in water. 
The hydrodynamic diameter of the SPION@ISA23-ND obtained in this way was smaller than 100 nm, 
sufficiently small size for in vivo applications, since the reticulo-endothelial system is less prone to 
recognizes and eliminate small NPs, especially if coated with zwitterionic coatings at physiological pH. 
SPION@ISA23-ND could be re-suspended after lyophilization and reverted to their pristine 
dimensions without sonication. Moreover, the SPION@ISA23-ND adsorption of BSA in water, considered 
as the first stage of phagocytosis, was only ~3%, compared with 23% for SPION@TMAOH, suggesting 
that ISA23 coating could impart stealth-like behavior in the bloodstream. 
Preliminary in vitro assays showed that SPION@ISA23-ND nanocomposite was well tolerated by Hela 
cells, where they localize inside lysosomes, as revealed by reflected light microscopy, exploiting their 
high scattering ability.  
Finally, a successful synthetic procedure was devised to obtain dual magneto-optical probes, 
conjugating a novel PAA bearing both catechol and Rhodamine B pendants to the SPION surface. Low 
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emission intensity was detected due to the luminescence quenching. Since this problem was likely due 
to the closeness of the RhodamineB to the SPION surface, it could be overcome by spacing the SPION 
surface and the dye moieties, through the introduction of new linkers. 
 
4. Experimental Part 
Chemical and Biological Materials 
All chemicals were purchased from Sigma Aldrich (including iron(0) pentacarbonyl) and used as 
received, if not otherwise specified.  
Ultrapure water (milli-Q, Millipore, resistivity = 18 M Ω cm−2) was used for the preparation of the 
aqueous solutions. 
Human cervical cancer epithelial HeLa cells (from human cervix adenocarcinoma) were purchased 
from the American Type Culture Collection (ATCC-CCL2). 
Minimal Essential Medium (MEM), Dulbecco modified Phosphate Buffer Saline (DPBS), Trypsin 
solution (porcine trypsin-EDTA 0.05%) and Fetal Bovine Serum (FBS) were purchased from Gibco, 
Thermo Fisher Scientific. Complete medium (CMEM) was obtained by supplementing MEM with 10% 
FBS not heat inactivated (50 ml FBS added to 500 mL MEM). 
Bovine serum albumin (50 kDa) was purchased from Sigma Aldrich. 
 
Instruments 
NMR experiments were performed on a Bruker DRX400 spectrometer equipped with a Bruker 5 mm 
BBI Z-gradient probe head with a maximum gradient strength of 53.5 G/cm in D2O. 
DLS and ζ-potential measurements were performed using a Malvern Zetasizer nano ZS instrument at 
25°C, equipped with a 633 nm solid state He–Ne laser at a scattering angle of 173°, typically dissolving 
samples at concentration 1 mg/mL or less. The size and charge measurements were averaged from at 
least three repeated measurements. 
UV−vis absorption spectra were acquired on an Agilent model 8543 spectrophotometer at room 
temperature and using standard quartz cells with 1.0 cm path length. 
Emission spectra were obtained with an Edinburgh FLS980 spectrofluorimeter equipped with a 450 
W xenon arc lamp. Emission spectra were corrected for source intensity (lamp and grating) and emission 
spectral response (detector and grating) by standard correction curves. Photoluminescence quantum 
yields were measured with a Hamamatsu Photonics absolute PL quantum yield measurement system 
(C11347-01 Quantaurus spectrometer) equipped with a L11562 Xenon light source (150 W), 
monochromator, C7473 photonic multi-channel analyzer, integrating sphere and employing U6039-05 
PLQY measurement software (Hamamatsu Photonics, Ltd., Shizuoka, Japan). 
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Thermogravimetric analysis. Thermogravimetric analysis (TGA) were performed in air in the 
temperature range 50 - 800 °C with a heating rate of 5°C min⁠−1, using a Mettler-Toledo 
thermogravimetric balance (TGA/DSC 2 Star⁠® System) on ca 5 mg of lyophilized samples. 
ATR-FTIR spectroscopy. IR spectra were acquired on a PerkinElmer Frontier equipped with an ATR 
accessory with a diamond/ZnSe crystal. 
Relaxometric characterization. The MRI contrast efficiency was assessed by means of 1H nuclear 
magnetic resonance (NMR) relaxometric characterization. The NMR measurements were performed at 
room temperature by measuring the longitudinal and the transverse nuclear relaxation times T1 and T2 
at the frequencies ν = 8.5, 21.3 and 63.8 MHz. The NMR signal detection and generation was obtained 
by Stelar Spinmaster Fourier transform-nuclear magnetic resonance (FT-NMR) spectrometer.  
Metal content on SPION was determined by a spectrophotometric method, digesting few microliters 
of nanoparticles suspension with 1 mL of concentrated HCL (37%) at RT for 1 night, directly in a 10 mL 
volumetric flask. Then, it was filled up with 100 uL of 10% w/w NH2OH, acetate buffer solution (pH 4.6, 
0.15 M, 6 mL), 1,10-phenantroline solution (0.6% w/w, H2O/MeOH 10 : 1, 0.2 mL), and finally brought to 
volume with milliQ water. The absorbance at 510 nm was then measured with an UV-vis 
spectrophotometer and plotted against standards prepared with the same procedure starting from a 
commercial iron AAS standard solution. 
Transmission Electron Microscopy (TEM) characterization. TEM images were collected through a Zeiss 
Libra 200 FE equipped with an in column pre-aligned omega filter that improves the contrast and a 
Schottky field emission gun at 200kV. Samples were prepared by dropping a water solution on a holy 
carbon copper grid, and after blotting the excess of water, the sample were let drying at least for 24 h in 
air. The nanoparticle size was measured by means the ITEM TEM Imaging Platform software (Olympus). 
For each sample the measured NPs were around 400. 
Reflected light microscopy. Experiments on cells were performed using Hela cells (ATCC CCL- 2) 
grown under standard conditions (5% CO2, 37 °C) in MEM medium (Gibco) supplemented with 10% fetal 
bovine serum (FBS from Gibco) (complete cell culture medium, CMEM). Samples for imaging were 
prepared by placing glass coverslips (VWR) on the bottom of a 24 wells plate before seeding cells. Hela 
cells were seeded at density 30×104 cells per well in 0.5 mL of complete medium. After 24 h of 
incubation at 37 °C in 5% CO2 the cell culture medium was replaced with freshly prepared dispersions in 
CMEM of SPION@ISA23-ND at a concentration of 50 μg/mL. After the required exposure times (24 h) 
the cells were washed once with CMEM (0.5 mL x 1) and with PBS (0.5 mL x 2), in order to remove the 
non-internalized NPs. Cells were fixed with 0.5 mL of formaldehyde (4%) for 15 min and then 
permeabilized with 0.5 mL 0.1% triton for 5 min. The cover slips were then washed three times with 
PBS.  The lysosomes were stained with a primary mouse monoclonal antibody against the lysosomal 
protein Lamp-1 (lysosome-associated membrane protein 1; antibody from BD Biosciences US) (dilution 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 19 
in PBS 1:100), and an Alexa Fluor-488 conjugated goat anti mouse secondary antibody (Thermo Fisher 
Scientific) (dilution in PBS 1:200), each for 60 min. The cover slips were mounted on a glass microscopy 
slide with Mowiol 4-88 mounting medium (EMD Chemical, Inc., CA, USA) and analysed after 24 h of 
incubation at RT in dark. Analysis was performed with a confocal microscope Leica TCS SP8: in order to 
detect the presence of nanoparticles, the reflected light was collected by placing the emission detector 
in the middle of the laser (excitation) beam. The settings were as follows: reflected light: 488 nm 
illumination and detector: 480-505 nm; Alexa Fluor 488 excitation: 488 nm laser; Alexa Fluor 488 
detector: 500-550 nm. 
Syntheses 
Synthesis of superparamagnetic iron oxide nanoparticles (SPION). The synthesis of SPION was 
performed following a slightly modified literature procedure [44]. Briefly for preparation A, in a 50 mL 
three-necked round bottom flask 13.9 mmol of oleic acid (4.38 mL, d= 0.895 g/mL) and 2 mmol of 
Fe(CO)5 (236 µL, d= 1.49 g/mL) were dissolved under inert atmosphere in 4 mL of 1-octadecene. In the 
second preparation (B) the total amount was increased and a 250 mL three-necked round-bottom flask 
employed, in which 60 mmol of oleic acid (19 mL, d= 0.895 g/mL) and 10 mmol of Fe(CO)5 (1.348 mL, d= 
1.49 g/mL) were dissolved under inert atmosphere in 40 mL of 1-octadecene. These solutions were then 
heated from room temperature to 320 °C at a rate of 15 °C/min and refluxed for 3 h. During this time 
the reddish solutions turned to black. The solutions were then cooled to 120°C at a rate of 5 °C/min and 
maintained at that temperature for 2 more hours in air to allow oxidation of Fe(0). The solutions were 
cooled down to room temperature at a rate of 5 °C/min. The SPION were subsequently isolated by 
centrifugation of the reaction mixture after addition of ca 70 mL (or 500 mL in the second procedure) of 
acetone (4 centrifugation cycles for 5 min at 5000 round centrifugal force, rcf) followed by removal of 
the yellow supernatant and addition of fresh acetone. The isolated particles were then re-suspended in 
15 mL (or 30 mL in the second procedure) of hexane and stored under nitrogen atmosphere at -25 °C for 
further uses. 
Synthesis of nitrodopamine. Dopamine·HCl (498 mg, 2.62 mmol) and NaNO3 (633 mg, 9.16 mmol) 
were dissolved at 0 °C in 15 mL water in a two-necked 50 mL round bottom flask under inert 
atmosphere. Then, 5 mL of 20% H2SO4 was added dropwise in the dark. The reaction mixture was left 
overnight at room temperature under magnetic stirring. The yellow precipitate was then filtered off, 
washed with ice cold water and cold methanol, and subsequently dried in vacuum, affording 338 mg of 
nitrodopamine.H2SO4 (1.14 mmol, 50.5% yield). 1H NMR (DMSO-d6, 300 K, 9.4 T): δ 7.45 (1H, CH), 6.60 
(1H, CH), 3.05 (4H, CH2). 
Synthesis of ISA23-nitrodopamine conjugate (ISA23-ND). Parent ISA23 (Mn = 29940, Mw = 44060, 
PD = 1.47), synthesized as described in reference [30], (335 mg, 1 mmol) was dissolved in degassed 2-(N-
morpholino)ethanesulfonic acid (MES) buffer (20 mL, 0.1 M) under inert atmosphere. The pH of the 
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solution was then carefully adjusted to 5.6 by addition of few drops of NaOH 1M. Then, nitrodopamine 
(296 mg, 1 mmol) was added, and the pH adjusted to 5.6, before the addition of the cross-linker EDC (1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, 575.1 mg, 3 mmol). The turbid yellow 
suspension quickly became less opaque. The reaction was left in the dark for 4 h under magnetic stirring 
and then filtered through a 3 kD cut-off centrifugal device to eliminate all the unreacted nitrodopamine, 
as well as the byproducts deriving from EDC, and further washed with water. The remaining yellow 
solution was lyophilized, finally affording 146.7 mg of a fluffy yellow product, ISA23-ND (42% yield). 1H-
NMR (D2O, 300 K, 9.4 T): δ 8.75 (1H, NHCO), 8.66 (1H, NHCO), 8.02 (1H, CH dopamine), 6.46 (1H, CH 
dopamine), 5.65 (1H, NHCOCHNHCO of minority fraction), 5.42 (1H, NHCOCHNHCO of majority fraction), 
3.75-2.25 (14 H CH2 and 1H CH of 2-Me-piperazine), 1.20 (3H, CH3). 
One-step ligand exchange. A n-hexane suspension of SPION@OA (320 μL, 15 mg/mL Fe3O4, 
preparation A) was first treated with 1.5 mL EtOH to eliminate the possible excess of OA, and the NPs 
recovered with a magnet and re-dispersed in 8 mL n-hexane. To this suspension a solution of the 
polymer ISA23-ND (14.4 mg dissolved in 12 mL water) was added, and the pH adjusted 3-4 with the 
addition of 80 µL 1 M HCl. The mixture was subsequently vortexed until an emulsion was formed and 
then left shaking for 72h with a vortex mixer. The organic phase became completely colorless, while the 
water phase passed from light yellow to brown. This last one was washed once with 10 mL hexane to 
remove possible OA still present. After the most of the organic phase was removed, the residues of 
hexane still present in the water phase were evaporated off at rotary evaporator. The water suspended 
SPION@ISA23-ND were then collected via centrifugation (10 min at 5000 rcf) before discarding the 
supernatant and re-dispersing the product in 5 mL water. This procedure was repeated twice in order to 
remove any remaining unbound polymer. 
Two-step ligand exchange with TMAOH. A solution of SPION@OA in hexane (430 μL, 10 mg Fe3O4, 
preparation B) was dried under a gentle N2 stream in a glass vial. Subsequently, a solution of 
TMAOH5H2O (450 mg dissolved in 2.36 mL water) was added and the vial was placed in an ultrasonic 
bath for few minutes in order to re-disperse the SPION. Then, the so obtained turbid suspension was 
diluted to 20 mL, affording a final concentration of Fe3O4 of 0.5 mg /mL. Ten milliliters of this solution (5 
mg SPION@TMAOH) were centrifuged (5 min, 20800 rcf), the NP pellet re-dispersed in a water solution 
of ISA23-ND (15 mg in 10 mL water, pH 3) and left shaking for 72h on a vortex mixer at room 
temperature. Then, the SPION@ISA23-ND were recovered with a magnet and re-dispersed in 10 mL 
milliQ water. Finally, the pH was increased to 9-10 and the solution was left shaking for other 24 h. The 
so obtained suspension was lyophilized giving rise to a brown powder, which was promptly re-
suspended in milliQ water by gently shaking. 
Synthesis of ISA23SH-ND conjugate. ISA23SH10% (Mn = 8250, Mw = 7000, PD = 1.18), prepared as 
previously described [67], (30 mg, 0.092 mmol) was dissolved under N2 atmosphere in 3 mL of 0.1M 
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MES buffer. To this solution nitrodopamine hydrogen sulphate (25.5 mg, 0.086 mmol) was added, 
forming a yellow suspension. Then, EDC (47.9 mg, 0.25 mmol) was added, and the pH was adjusted to 
5.4 with addition of 1M NaOH. The reaction proceeded for 4 h at room temperature, then filtered 
through a 3 kD cut-off centrifugal device to eliminate unreacted nitrodopamine, EDC and byproducts, 
and further washed with water until the filtrate portion resulted colorless. The retained yellow fraction 
was then recovered and lyophilized, obtaining 15.2 mg of ISA23SH-ND copolymer. 
Synthesis of ethylmaleimido-rhodamineB. The synthesis of 2-aminoethylmaleimide trifluoroacetate 
salt was carried out following a literature procedure [68]. 2-aminoethylmaleimide trifluoroacetate salt 
(2.4 mg, 9.3 x 10-3 mmol) was dissolved in an amber glass schlenk flask, under N2 atmosphere, in 0.5 mL 
EtOH. Then, a solution of rhodamine B isothiocyanate (4.7 mg, 9.3x10-3 mmol) and triethylamine (1.7 μL, 
1.3 eq) in 0.7 mL EtOH was added. The reaction was carried out in 12 h, at room temperature, in the 
dark and under magnetic stirring. The product was not isolated, and the solution used as it was for the 
next synthetic step.  
Conjugation of ISA23SH-ND with rhodamineB. ISA23SH-ND (15.2 mg, 0.0436 mmol) was dissolved in 
3.33 mL water in a Schlenk flask under inert atmosphere. To this solution 0.67 mL of ethanol solution of 
ethylmaleimido-rhodamineB (2.8 mg, 1 eq. with respect to –SH groups) was added. The reaction was left 
at room temperature in the dark for 72 h, then filtered through a 3 kD cut-off centrifugal device to 
eliminate unreacted rhodamine and further washed with water until the filtrate portion resulted 
colorless. The solution was then lyophilized, recovering a purple polymer that was then dissolved in 2 
mL milliQ water. The rhodamineB concentration in this solution was determined 
spectrophotometrically, using its known 560= 86.000, and was found to be 0.2 mM. 
Two-step ligand exchange with ISA23SH-ND-RhodamineB. A hexane SPION@OA clear suspenion 
(430 μL, 10 mg Fe3O4) was dried under gentle N2 stream in a glass vial. Then, a solution of TMAOH5H2O 
(450 mg dissolved in 2.36 mL water) was added and the vial was placed in an ultrasonic bath in order to 
redisperse the SPIONs. The resultant suspension was diluted to 20 mL with milliQ water, affording a final 
0.5 mg /mL Fe3O4 concentration. An aliquot of this suspension (6 mL, 3 mg Fe3O4@TMAOH) was 
centrifuged (7.5 min, 20800 rcf) to eliminate the most excess TMAOH, then the pellet was re-dispersed 
in 6 mL of ISA23SH-ND-RhodamineB solution (3 mg, pH 3) and left shaking for 72h on a vortex mixer. 
The excess polymer was removed by centrifugation (5 min x 20.000 rcf). The retrieved NPs were washed 
twice with milliQ water and finally recovered by centrifugation (10 min x 10.000 rcf). 
Determination of bovine serum albumin adsorbed on SPION@ISA23-ND and SPION@TMAOH. The 
NPs (0.3 mL containing 0.35 mg/mL of SPION@TMAOH or SPION@ISA23-ND) were added to 1 mL of 
phosphate buffer solution (10-3 M, total ionic strength 0.05 adjusted by addition of KNO3) of bovine 
serum albumin (BSA, 0.1 mg/mL). The suspensions were incubated for 90 min at room temperature on a 
vortex mixer. The magnetic nanocomposites were then separated in a pellet by centrifugation for 15 
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min at 20100 g, before determining the relative concentration of BSA in the supernatant by UV-vis 
spectroscopy comparing the absorbance (λmax = 278 nm) with the one of the native BSA solution. 
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